Variant report
Variant | esv3392777 |
---|---|
Chromosome Location | chr2:206127317-206127652 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549488797 | chr2:206127380-206127381 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10202153 | chr2:206127438-206127439 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs535036706 | chr2:206127443-206127444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs369207159 | chr2:206127459-206127460 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181688014 | chr2:206127463-206127464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538984145 | chr2:206127470-206127471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557285738 | chr2:206127477-206127478 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575545105 | chr2:206127516-206127517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113250656 | chr2:206127524-206127525 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542437543 | chr2:206127544-206127545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs112437097 | chr2:206127572-206127573 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572817139 | chr2:206127574-206127575 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540232298 | chr2:206127575-206127576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs564493444 | chr2:206127609-206127610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545673681 | chr2:206127615-206127616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10204712 | chr2:206127621-206127622 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Cervical cancer | 21062161 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 16573809 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cancer | 20164920 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:206097200-206170600 | Weak transcription | HSMMtube | muscle |
2 | chr2:206108400-206145200 | Weak transcription | HSMM | muscle |
3 | chr2:206113400-206139800 | Weak transcription | Pancreas | Pancrea |
4 | chr2:206118200-206156600 | Weak transcription | Aorta | Aorta |
5 | chr2:206126000-206127400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr2:206126400-206127600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
7 | chr2:206126600-206127600 | Enhancers | Osteobl | bone |
8 | chr2:206127000-206127400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr2:206127200-206127400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr2:206127400-206128000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |